Signet - Sky9 Capital 云九资本

Signet

Healthcare

Targeted cancer drugs and cell-based organoid development

Signet Therapeutics empowers targeted cancer drug discovery and development using novel disease models.

Founder and CEO

Favorite Innovator

Accept the things I cannot change. Change the things I can.

Reinhold Niebuhr

Silicon Valley

1050 Sansome St, San Francisco, USA
CA 94111

Singapore

6 Raffles Quay #14-07, Singapore
048580

Beijing

Suite 1803 B, Tower F, Phoenix Place A5 Shuguang Xili, Chaoyang District
100028

Shanghai

Suite 1807, Tower 1, Raffles City Changning 1133 Changning Road, Changning District
200051